Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Technology and Innovation

MedTech Town Hall

Panel Discussion | The Next Wave of Innovation in Interventional Cardiology | Coronary DCBs, Innovative Left-Atrial-Appendage-Closure, Imaging, Left Atrial Shunts, and Novel Heart Failure Management Technologies - The CMO roundtable

Tuesday, March 11, 2025
10:30 AM – 10:50 AM ET

    Panel Moderator(s)

  • Lawrence Biegelsen, MBA

    Managing Director Medical Supplies & Devices
    Wells Fargo
    Short Hills, New Jersey, United States

    Disclosure(s): No financial relationships to disclose

  • Rick Wise, CFA

    Research Analyst
    Stifel
    New York, New York, United States

    Disclosure(s): No financial relationships to disclose

    • Panel Discussant(s)

  • William T. Abraham, MD

    Professor of Medicine
    The Ohio State University
    Columbus, Ohio, United States

    Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)

  • Dominic Allocco, MD, MS

    Associate Chief Medical Officer
    Shockwave/Johnson & Johnson, Minnesota, United States

    Disclosure(s): Boston Scientific: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave/Johnson&Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Steven R. Bailey, MD, MSCAI

    Professor of Medicine
    LSU Health Shreveport
    San Antonio, Texas, United States

    Disclosure(s): No financial relationships to disclose

  • Rafael Cavalcante, MD, PhD

    Vice President, Medical Affairs
    Boston Scientific
    Newton, Massachusetts, United States

    Disclosure information not submitted.

  • Samuel Conaway, MBA

    President Cardiology Sales
    Boston Scientific Corporation

    Disclosure(s): No financial relationships to disclose

  • Haim Danenberg, MD

    Head of interventional cardiology
    Wolfson Medical Center
    Holon, Israel

    Disclosure(s): Abbott Cardiovascular Systems: clinical proctor (Ongoing)

  • Manish Doshi, PhD

    Founder and Managing Director
    Concept Medical, Florida, United States

    Disclosure(s): Concept Medical: Employee (Ongoing), Stock-privately held company (Ongoing)

  • Jeffrey J. Popma, MD

    CRF
    Newton, Massachusetts, United States

    Disclosure(s): Medtronic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

  • Patrick W. Serruys, MD, PhD

    Professor of Medical Intervention & Innovation
    University of Galway, Ireland

    Disclosure(s): Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Charles A. Simonton, MD, FACC, FSCAI

    EVP Chief Medical Officer
    Abiomed a Johnson + Johnson MedTech Company
    Charlotte, North Carolina, United States

    Disclosure(s): Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)

  • JW

    Jason Weidman

    Disclosure information not submitted.

Disclosure(s):
Lawrence Biegelsen, MBA: No financial relationships to disclose
Rick Wise, CFA: No financial relationships to disclose
William T. Abraham, MD: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)
Dominic Allocco, MD, MS: Boston Scientific: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave/Johnson&Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Steven R. Bailey, MD, MSCAI: No financial relationships to disclose
Samuel Conaway, MBA: No financial relationships to disclose
Haim Danenberg, MD: Abbott Cardiovascular Systems: clinical proctor (Ongoing)
Manish Doshi, PhD: Concept Medical: Employee (Ongoing), Stock-privately held company (Ongoing)
Jeffrey J. Popma, MD: Medtronic: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Patrick W. Serruys, MD, PhD: Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Charles A. Simonton, MD, FACC, FSCAI: Johnson and Johnson: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing)